Mary Joan Macleod MB ChB PhD FRCP has a personal Chair in Clinical Pharmacology at the University of Aberdeen, and is an Honorary Consultant Physician at NHS Grampian. Her main research interests are stroke epidemiology (particularly how service organisation and treatment affect outcomes after stroke), stroke clinical trials and stroke imaging (particularly low field MRI). She is responsible for assessment of the final year of the MBChB course. Other roles include 1:6 cover of acute stroke admissions, Chair of NHS Grampian/University of Aberdeen Clinical Studies Oversight Group, Clinical Lead of the Scottish Stroke Care Audit and Honorary Deputy Secretary of the British and Irish Association of Stroke Physicians. Former roles include Chair of Scotland A and B Research Ethics Committees.

Isla Mackenzie is Professor of Cardiovascular Medicine and Associate Dean for Research in the School of Medicine, University of Dundee. She is an Honorary Consultant Physician at Ninewells Hospital, Dundee and contributes to the cardiovascular risk clinical service. She has led several cardiovascular clinical trials and is a member of the BHF Clinical Studies Committee. In 2018, she was awarded the Grahame-Smith Prize for Clinical Pharmacology by the British Pharmacological Society for outstanding contributions to research in clinical pharmacology.

Christian Delles is Professor of Cardiovascular Prevention, Interim Director of the Institute for Cardiovascular and Medical Sciences, University of Glasgow, and Honorary Consultant Physician with NHS Greater Glasgow & Clyde. His research is in the area of cardiovascular diseases where he studies markers for early diagnosis of diabetic nephropathy; the molecular basis of vascular diseases; the pathogenesis and long-term consequences of hypertensive disorders of pregnancy and gestational diabetes; and differences in the pathophysiology of cardiovascular diseases between men and women. Prof. Delles serves as Treasurer of the British and Irish Hypertension Society and Honorary Secretary of the Association of Physicians of Great Britain and Ireland. He is a member of national and international grant panels and associate editor and editorial board member of leading cardiovascular journals. He has a keen interest in teaching and training and currently chairs the University's Clinical Academic Training Advisory Committee.

Bill Simpson was born and grew up in Glasgow. He studied medicine there, graduating in 1984, and continued to spend his early post graduate years around Central Scotland. In 1990 he moved to Aberdeen to finish his training in Chemical Pathology. As a fellow of the Royal College of Pathologists, he held a Consultant post in the Clinical Biochemistry Department of Aberdeen Royal Infirmary from 1997 to 2022. His main areas of clinical and research interest were lipids and nutrition. In 2006 he brought together some interested colleagues to form the Scottish Lipid Forum (SLF), the aim being to provide an educational programme and to develop and share strategies for the best treatment of hyperlipidaemias across Scotland. This proved quite popular, and was adopted as a vehicle for roll out of the screening programme for Familial Hypercholesterolaemia in Scotland. This opened up invitations to speak at locations from Aberdeen to Australia. Probably his most significant achievement was with a PowerPoint slide during a talk on FH in Westminster. The slide was completely blank, but the commentary, "What England is doing about FH", was taken as a wake up call by NHS England! Bill remains active in SLF and many of the other notable organisations for which he has held national roles: The Association for Clinical Pathologists (ACP) - Past President, Treasurer, and previously Chair of the Scientific Advisory Committee on Chemical Pathology; the Association for Clinical Biochemistry (ACB) - Chair and Secretary of ACB Scotland, founding Chair of the Nutrition Group of the Clinical Practice Section; Academy of the Medical Royal Colleges - organiser of the Scottish Inter-Collegiate Nutrition Course; Royal College of Pathologists - Regional Tutor, Specialty Advisor, member of the National Quality Assurance Panel; HEART UK founder member and Champion for FH Scotland, and of course SHARP - previous co-Chair, long serving trustee, and currently treasurer.

GP with an interest in cardiology and respiratory medicine. SRU Referee and International Time Keeper in my spare time, practising what I preach by keeping active. Trained under Dr TS Callaghan in Angus, when I learned how to do echocardiograms and had my own echo list at Arbroath infirmary in 2000-2001. Member of SHARP since 2001, Chair 2018/19. Member of the Angus CHP Cardiovascular Clinical Working Group from 2001, Chair from 2004-2016, during which I helped to deliver cardiovascular education at PLT and SHARP events. I was Angus Rep on the Tayside Cardiovascular MCN from 2010-2012, when I was Clinical Director for Angus CHP. GP on the SIGN Guideline 148 Acute Coronary Syndrome update in 2016.

Jill Belch is a Professor of Vascular Medicine at the University of Dundee, UK. She is a founder Trustee of SHARP and Founder Fellow of the UK Academy of Medical Science and a Fellow of the Royal Society, Edinburgh. Her research interests centre on cardiovascular disease with especial reference to peripheral arterial disease (PAD), air pollution and the microvasculature. She is the Medical School’s Chair of the Sustainability committee, and co-chairs the short-term working group on Air Pollution at the Royal College of Physicians, Edinburgh. She is Immediate Past President of both the UK Section of Vascular Medicine at the Royal Society of Medicine and the European Society of Vascular Medicine (ESVM), for whom she also chairs the ESVM Guidelines Committee.

Dr Alan Cameron is a Senior Clinical Lecturer at the University of Glasgow and a Consultant Stroke Physician. He leads a research programme that aims to prevent cardioembolic strokes through improved detection and management of atrial fibrillation (AF). He was awarded a PhD in Cardiovascular Medicine from the University of Glasgow’s British Heart Foundation Centre of Research Excellence in 2019. He contributes to international collaborative efforts as Chair of the European Stroke Organisation (ESO) Brain and Heart Council, is a Fellow of the ESO, and an active member of the AF-Screen International Collaboration. His research aims to improve outcomes for individuals with cardiovascular disease and stroke.

Dr Rosemary Clarke is Consultant Medical Biochemist in NHS Highland, and is an Honorary Clinical Lecturer at University of Aberdeen. She trained in Chemical Pathology with Metabolic Medicine in London before moving to NHS Highland to lead the Lipid and Point Of Care services. She also works within the Blood Sciences Laboratory and is block lead for medical student diagnostics teaching. She has an extensive academic research background having completed two Masters and a PhD, and an ongoing commitment to drive quality improvement on a local and national level.

Morven is a cardiology nurse with almost 30 years of experience in a plethora of speciality clinical roles involving establishing and running innovative person-centred cardiology services such as a nurse led atrial fibrillation service. She has worked nationally for the British Heart Foundation testing, implementing, and supporting development new pathways of care. She is passionate about education and has worked in healthcare education in both further education & university settings. She led the codesign of the implementation plan of Scottish Cardiac Audit Programme, in collaboration with those with lived experience, clinicians and service providers. She currently works in Forth Valley as the Quality and Safety Lead with a passion of supporting codesign improvement of care with service users.

Jonathan works as a lipid specialist at the Royal Infirmary of Edinburgh, and as a medical biochemist within the department of laboratory medicine in NHS Lothian. He is a previous chair of the Scottish Lipid Forum and in recent years has worked with Scottish government groups tasked with improving cardiovascular disease prevention. He also currently chairs a Scottish network group of clinicians and clinical scientists with an interest in lipid disorders.

Dr Ify Mordi is a Consultant Cardiologist in NHS Tayside and a Clinical Senior Lecturer at the University of Dundee. He has clinical and research interests in all aspects of cardiovascular disease, but in particular heart failure and cardiometabolic disease.

In April/May 2019, before the COVID-19 pandemic, John began experiencing troubling symptoms that went beyond his asthma. Recognising the severity of his breathing difficulties, his daughter rushed him to the hospital one night, a decision that likely saved his life. This marked the beginning of a nine-week hospitalisation where doctors diagnosed him with blood clots in his heart and lungs, along with pneumonia. About a year later, John underwent a procedure to have a defibrillator fitted. In the years following this challenging time, he received the reassuring news that his heart was functioning normally. Today, John focuses on his well-being by attending weekly exercise classes and aims to further increase his activity level.

Professor Lis Neubeck is cardiac nurse with over 25 years of experience in a range of cardiac in-patient and out-patient settings. She is Professor of Cardiovascular Health in the School of Health and Social Care and Head of the Centre for Cardiovascular Health at Edinburgh Napier University. Her research focuses on innovative solutions to secondary prevention of cardiovascular disease, identification and management of atrial fibrillation, and use of digital health to improve access to health care. Lis is the NHS Research Scotland Cardiovascular Clinical Network Lead, immediate Past President of the Association of Cardiovascular Nursing and Allied Professionals of the European Society of Cardiology (ESC) and ESC patient forum lead.

After graduating from Robert Gordon University in 2002 and completing her Pre-registration year in Community Pharmacy, Lyndsay has continued to learn and diversify in her career ever since. Her pharmacy travels began in 2004 when she travelled to Australia and completed registration as a pharmacist. Over the years, she has worked in many areas of pharmacy including Community, Primary Care, Secondary Care, the Scottish Medicines Consortium, and NES. She has completed a Diploma in Clinical Pharmacy, Independent Prescribing Qualifications, Cardiology Teach and Treat Training, and Advanced Clinical Examination Skills. In 2015, she moved back to Australia for four years where she worked as a Cardiology Specialist Pharmacist, with a particular interest in the safe and effective management of anticoagulants. In 2019, she returned to Scotland to take up the post of Lead General Practice Pharmacist in NHS Orkney, where she currently works with a small yet fabulous team of clinical pharmacists in General Practice. Her main areas of interest are Cardiology and Respiratory, although with a role in General Practice Pharmacy, every day is a learning day and her skillset is constantly being enhanced through excellent interprofessional working relationships with GPs, nurses, and other allied health and social care staff on Orkney and beyond. She is extremely interested in how, as a team, they can improve the way patients take their medicines, reduce side effects, enhance medication-related benefits, and reduce medicines wastage. Another key interest lies in how the pharmacy profession can adapt, enhance, and learn in this rapidly changing career framework era. In line with her passion for education, she also works as a Scottish Pharmacy Clinical Academic Research Fellow with NHS Education for Scotland, Robert Gordon University, and HIPER, where her research focuses on Simulation-Based Education. She hopes this work will help support pharmacists to work autonomously as confident, independent prescribing clinicians.

Paul is an epidemiologist with a wide range of research interests encompassing biomarkers, lifestyle, and clinical research in cardiovascular disease, diabetes, metabolism, and healthy aging, including influential clinical trials, large observational studies, and meta-analyses. His eclectic portfolio of work includes >300 publications with an H-index of >65. Recently, he has worked on revising the Scottish national cardiovascular risk score, ASSIGN 2, which is now being integrated into clinical practice. Paul founded and leads the Glasgow Biomarker Research Unit (GlasBRU) at University of Glasgow. GlasBRU was developed to drive a cross-sector collaboration between University of Glasgow, Roche Diagnostics and NHS Greater Glasgow and Clyde, culminating in the funding of the Glasgow Biomarker Centre of Clinical Excellence in Heart Failure. This innovative long-term partnership aims to identify and address the unmet needs of heart failure patients in optimising the care pathway. His group also collaborates extensively with AstraZeneca, Novartis, Boehringer Ingelheim and other industrial partners.